XML 26 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
SHAREHOLDERS' EQUITY: (Details) (USD $)
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Sep. 30, 2012
Provalliance
Dec. 31, 2012
Provalliance
Dec. 31, 2012
Stock options
Dec. 31, 2011
Stock options
Dec. 31, 2012
Stock options
Dec. 31, 2011
Stock options
Dec. 31, 2012
SARs
Dec. 31, 2011
SARs
Dec. 31, 2012
SARs
Dec. 31, 2011
SARs
Dec. 31, 2012
Shares issuable upon conversion of debt
Dec. 31, 2012
Shares issuable upon conversion of debt
Dec. 31, 2011
Shares issuable upon conversion of debt
Dec. 31, 2012
Common Stock
Dec. 31, 2012
RSAs
Dec. 31, 2011
RSAs
Dec. 31, 2012
RSAs
Dec. 31, 2011
RSAs
Dec. 31, 2012
RSUs
Dec. 31, 2011
RSUs
Dec. 31, 2012
RSUs
Dec. 31, 2011
RSUs
Reconciliation of the net (loss) income available to common shareholders and the net (loss) income for diluted earnings per share                                                    
Net (loss) income from continuing operations available to common shareholders $ (16,119,000) $ 11,900,000 $ 18,528,000 $ 17,523,000                                            
Effect of dilutive securities:                                                    
Interest on convertible debt, net of taxes   2,078,000                                                
Net (loss) income from continuing operations for diluted earnings per share (16,119,000) 13,978,000 18,528,000 17,523,000                                            
Weighted average common and common equivalent shares outstanding:                                                    
Weighted average shares for basic earnings per share 56,794,000 56,857,000 57,043,000 56,853,000                                            
Effect of dilutive securities:                                                    
Dilutive effect of stock-based compensation (in shares)   357,000 82,000 306,000                                            
Dilutive effect of convertible debt (in shares)   11,203,000                                                
Weighted average shares for diluted earnings per share 56,794,000 68,417,000 57,125,000 57,159,000                                            
Additional Paid-In Capital:                                                    
Decrease in additional paid-in capital     12,600,000                                              
Stock repurchase program authorized amount     300,000,000                                              
Repurchase of common stock 14,868,000   14,868,000                                              
Repurchases of common stock (in shares) 909,175                                                  
Outstanding repurchase amount under stock repurchase program     58,700,000                                              
Awards excluded from earnings per share calculations                                                    
Awards excluded from basic earnings per share computation (in shares) 671,000 1,006,000 671,000 1,006,000                           98,637 482,000 791,000 482,000 791,000 189,000 215,000 189,000 215,000
Awards excluded from diluted earnings per share computation (in shares) 13,015,000 1,815,000 12,835,000 13,207,000     579,000 810,000 600,000 810,000 1,001,000 999,000 895,000 999,000 11,255,000 11,247,000 11,195,000     6,000   203,000 180,000   93,000  
Accumulated Other Comprehensive Income:                                                    
Foreign currency translation rate gain adjustments           43,400,000                                        
Cross-currency swap net loss           7,900,000                                        
Cash repatriation net loss           1,700,000                                        
Accumulated other comprehensive income     $ (33,842,000)   $ 33,800,000 $ 33,800,000